NOTE: This disposition is nonprecedential. United States Court of Appeals
for the Federal Circuit
COSMO TECHNOLOGIES LIMITED, VALEANT
PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS LUXEMBOURG
S.A.R.L.,
Plaintiffs-Appellants
v.
ACTAVIS LABORATORIES FL, INC.,
Defendant-Appellee
2018-1335
Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-00164-LPS, Chief Judge Leonard P. Stark.
COSMO TECHNOLOGIES LIMITED, VALEANT
PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS LUXEMBOURG
S.A.R.L.,
Plaintiffs -Appellants
v.
2ALVOGEN PINE BROOK, LLC,
Defendant-Appellee
2018-1336
Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-00193-LPS, Chief Judge Leonard P. Stark.
JUDGMENT
STEPHEN BLAKE KINNAIRD, Paul Hastings LLP, Washington, DC, argued for all plaintiffs-appellants. Plaintiffs-appellants Valeant Pharmaceuticals International, Valeant Pharmaceuticals Luxembourg S.a.r.l. also represented by IGOR VICTOR TIMOFEYEV; MELANIE R. RUPERT, New York, NY. GARY N. FRISCHLING, Irell & Manella LLP, Los Angeles, CA, for plaintiff-appellant Cosmo Technologies Limited. Also represented by YITE JOHN LU. WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for defendant-appellee Actavis Laboratories FL, Inc. Also represented by JOHN T. BENNETT, JOSHUA JAMES BONE, SAMUEL SHERRY, Boston, MA; ELIZABETH HOLLAND, NAOMI BIRBACH, New York, NY. JASON MURATA, Axinn, Veltrop & Harkrider LLP, San Francisco, CA, argued for defendant-appellee Alvogen Pine Brook, LLC. Also represented by MATTHEW BECKER, Hartford, CT.
3THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
TARANTO, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
January 14, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court